Aegis Therapeutics LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Aegis Therapeutics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011813
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aegis Therapeutics LLC (Aegis Therapeutics) is a biotechnology company that research and develops drug delivery and drug formulation technologies. The company commercializes new drug delivery and protein stabilization technologies through product specific licenses to pharmaceutical and biopharmaceutical companies. It provides a drug delivery technology that allows the non invasive delivery of a broad range of protein, peptide, nucleotide, non peptide and other small and large molecule drugs. Aegis Therapeutics also provides protein stabilization technology, which creates homogeneous, stable, aqueous or lyophilized dosage forms for peptide or protein therapeutics. Aegis Therapeutics is headquartered in San Diego, California, the US.

Aegis Therapeutics LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Aegis Therapeutics Enters into Co-Development Agreement with Albany Medical College 10
Licensing Agreements 12
Opiant Pharma Enters into Licensing Agreement with Aegis Therapeutics 12
Dauntless Pharma Enters into Licensing Agreement with Aegis Therapeutics 14
Biodel Enters Into Licensing Agreement With Aegis Therapeutics For ProTek And Intravail Technologies 15
Aegis Therapeutics LLC – Key Competitors 16
Aegis Therapeutics LLC – Key Employees 17
Aegis Therapeutics LLC – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Key Facts 2
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aegis Therapeutics LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aegis Therapeutics Enters into Co-Development Agreement with Albany Medical College 10
Opiant Pharma Enters into Licensing Agreement with Aegis Therapeutics 12
Dauntless Pharma Enters into Licensing Agreement with Aegis Therapeutics 14
Biodel Enters Into Licensing Agreement With Aegis Therapeutics For ProTek And Intravail Technologies 15
Aegis Therapeutics LLC, Key Competitors 16
Aegis Therapeutics LLC, Key Employees 17

★海外企業調査レポート[Aegis Therapeutics LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ig Group Holdings Plc:企業の戦略・SWOT・財務分析
    Ig Group Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary Ig Group Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Tree Top, Inc.:企業の戦略・SWOT・財務分析
    Tree Top, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tree Top, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Berkshire Hathaway Energy Co-エネルギー分野:企業M&A・提携分析
    Summary Berkshire Hathaway Energy Company (BHE), a subsidiary of Berkshire Hathaway Inc., generates, transmits, stores, distributes, and supplies electricity; and procures, transports, distributes and sells natural gas through its subsidiaries. It generates power through diversified energy sources s …
  • Valentino Fashion Group S.p.A:企業の戦略・SWOT・財務情報
    Valentino Fashion Group S.p.A - Strategy, SWOT and Corporate Finance Report Summary Valentino Fashion Group S.p.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Neiman Marcus Group Ltd. LLC:企業の戦略的SWOT分析
    Neiman Marcus Group Ltd. LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Oman Oil Marketing Co (OOMS):企業の財務・戦略的SWOT分析
    Summary Oman Oil Marketing Co (Oman Oil), a subsidiary of Oman Oil Company SAOC, is an oil and gas company that distributes and markets petroleum products. The company provides products such as lubricants, fuel cards, aviation fuels, commercial fuels and bunkering marine fuels, among others. It offe …
  • Laboratory Corporation of America Holdings:企業のM&A・事業提携・投資動向
    Laboratory Corporation of America Holdings - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Laboratory Corporation of America Holdings Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Pacific Edge Ltd (PEB):企業の財務・戦略的SWOT分析
    Summary Pacific Edge Ltd (PEB) is a diagnostics company that develops, discovers, and commercializes diagnostic tests for the early detection and monitoring of cancer. It offers lead products such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It also develops Cxco …
  • Numaligarh Refinery Ltd:企業の戦略的SWOT分析
    Numaligarh Refinery Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Entercom Communications Corp (ETM):企業の財務・戦略的SWOT分析
    Summary Entercom Communications Corp (Entercom) is a provider of media and entertainment services. The company offers radio broadcasting programs. It owns and operates radio stations in various formats, including classic rocks, sports, news, talk, adult contemporary, alternative and country and othe …
  • The McClatchy Company:企業の戦略・SWOT・財務分析
    The McClatchy Company - Strategy, SWOT and Corporate Finance Report Summary The McClatchy Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • InfraReDx Inc-医療機器分野:企業M&A・提携分析
    Summary Infraredx Inc (Infraredx), a subsidiary of Nipro Corp is a medical device company that provides cardiovascular imaging solutions. The company offers TVC imaging system, a dual-modality intravascular imaging system that assesses plaque composition and vessel structure. Its TVC imaging system …
  • Marubeni Corporation (8002)-石油・ガス分野:企業M&A・提携分析
    Summary Marubeni Corporation (Marubeni) is an integrated trading and investment business that operates through its domestic and overseas subsidiaries. It provides various products and commodities such as agri and marine products, chemicals, energy, metals and minerals, machinery, textiles, forest pr …
  • ImaBiotech SAS-製薬・医療分野:企業M&A・提携分析
    Summary ImaBiotech SAS (ImaBiotech) is a contract research organization that provides mass spectrometry imaging services. The organization offers software products such as multimaging and quantinetix. Its service portfolio includes consulting and training, biomarker discovery, pharmaco-kinetics and …
  • Abreos Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Abreos Biosciences Inc (Abreos) is a biotechnology company with focus on the development of laboratory-based and point-of-care (POC) assays and reagents for the precision dose monitoring of biologic drugs. Its Monator, is a drug-monitoring test that provides physicians with vital information …
  • Sedia Biosciences Corp:製品パイプライン分析
    Summary Sedia Biosciences Corp (SBC) is a medical device company that offers diagnostic products. The company provides medical devices, diagnostic devices, HIV incidence products, rapid point of care assays and specimen collection devices. It also offers diagnostic products, epidemiological products …
  • Rex International Holding Ltd (5WH):石油・ガス:M&Aディール及び事業提携情報
    Summary Rex International Holding Ltd (Rex International), formerly Rex International Holding Pte Ltd is an independent exploration and production oil company. The company develops oil and gas properties across Singapore. It operates substantial oil and gas exploration concessions in the UAE, Oman, …
  • Legal & General Group Plc:戦略・SWOT・企業財務分析
    Legal & General Group Plc - Strategy, SWOT and Corporate Finance Report Summary Legal & General Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • China Power Clean Energy Development Co Ltd (735):電力:M&Aディール及び事業提携情報
    Summary China Power Clean Energy Development Co Ltd (CPCE) formerly China Power New Energy Development Co Ltd, is an electric utility. It develops, constructs, owns, operates, and manages clean energy power plants. The company produces electricity through natural gas, wind, hydro, and solar sources. …
  • Grupa Lotos SA (LTS)
    Grupa Lotos SA (LTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company

◆H&Iグローバルリサーチ株式会社のお客様(例)◆